This inventor holds 2 USPTO granted patents and 10 published patent applications. Top assignee: Abbvie Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gurnee, IL (US) (2023)
- North Chicago, IL (US) (2023)
Company Filing History:
Years Active: 2023
Title: Mohamad Shebley: Innovator in Gynecological Treatments
Introduction
Mohamad Shebley is a notable inventor based in Gurnee, IL (US). He has made significant contributions to the field of gynecological treatments, holding 2 patents that focus on innovative methods for addressing various women's health issues.
Latest Patents
His latest patents include "Methods of administering elagolix," which relates to the use of GnRH receptor antagonists for the treatment of endometriosis, uterine fibroids, polycystic ovary syndrome (PCOS), or adenomyosis. This patent describes methods for treating these gynecological disorders through the administration of elagolix, potentially in combination with CYP2B6 or CYP2C19 substrates. Another significant patent is "Methods of treating heavy menstrual bleeding," which outlines a method for treating heavy menstrual bleeding in subjects with or without uterine fibroids. This method involves administering an effective amount of a specific compound in combination with estrogens and progestogens.
Career Highlights
Mohamad Shebley is currently employed at AbbVie Inc., where he continues to work on innovative solutions in the healthcare sector. His expertise and dedication to improving women's health have made him a valuable asset to his company and the medical community.
Collaborations
He collaborates with talented coworkers, including Farah N Ali and Nael M Mostafa, who contribute to the advancement of research and development in their field.
Conclusion
Mohamad Shebley is a distinguished inventor whose work in gynecological treatments has the potential to significantly impact women's health. His innovative patents and ongoing contributions to AbbVie Inc. highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
